Kateryna Vilchevska

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Tadashi Matsushita, Amy D. Shapiro, Aby Abraham et al. · New England Journal of Medicine · 2023 · 91 citations · Full text

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

Philippe Moreau, Ievgenii Karamanesht, Maryna Kyselyova et al. · Clinical Pharmacokinetics · 2012 · 84 citations

Hematological Malignancy, Oncology, Relapsed Multiple Myeloma +6

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Tadeusz Robak, Jerzy Windyga, Jacek Treliński et al. · Blood · 2012 · 54 citations

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Gili Kenet, Beatrice Nolan, Bülent Zülfikar et al. · Blood · 2024 · 33 citations · Full text

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study

Ri Liesner, Aby Abraham, Carmen Altisent et al. · Thrombosis and Haemostasis · 2021 · 27 citations · Full text

Inhibitor Titres, Immunohematology, Immunodeficiencies +17